Introduction: 'bet-hedging' during fateselection decisions
Biological systems use two general strategies to maintain fitness in variable, fluctuating environments. One strategy involves the evolution of sophisticated sensor-actuator networks that continually assess environmental surroundings and adapt, generating a tailored response to a given surrounding. Sensor-actuator strategies appear throughout bacterial chemotaxis systems and osmoregulation [1] [2] [3] [4] [5] . An alternate strategy, proposed 50 years ago by the theoretical ecologist Dan Cohen [6] , involves probabilistically generating a range of different phenotypes in any given environment. While studying desert annual plants, where reproductive success is governed by unpredictable weather patterns, Cohen noted that fitness could be enhanced if seeds varied in their germination potential, allowing chance to govern each seed's fate to germinate or not. For example, if husk thickness of each seed is allowed to stochastically vary, a fraction of seeds will randomly remain non-germinated regardless of the environment, leaving a long-lived sub-population to avoid extinction during long-term droughts. Borrowing from economic theory, Cohen proposed that biological organisms could 'hedge their bets' in much the same way that financial houses diversify their assets -between higherrisk (higher-yield) stocks and lower-risk (lower-yield) securities -in order to minimize risk against market crashes.
Stochastic gene expression enables 'bethedging': from theory to the initial HIV evidence
For many years, the molecular mechanisms enabling biological systems to probabilistically hedge their bets between alternate developmental fates remained unclear. Viruses proved to be powerful model systems to define core regulatory principles underlying bet-hedging decisions. Viruses optimize fitness in variant cellular environments (i.e., target rich vs. target poor) and do so under strong genetic constraints, selecting for minimalist regulatory circuits (RNA virus genomes are typically 10 kB, thereby precluding sophisticated environmental sensing and actuation that require multiple genes and substantial genomic real estate). In the late 1990s, mathematical models of the lysis-lysogeny fate decision in the bacterial virus phage l suggested that a basic biophysical phenomenon intrinsic to life at the single-cell level -molecular fluctuations driven by Brownian diffusion -could generate the variability required for a developmental bethedging decision [7] . These diffusion-driven Brownian fluctuations in regulatory enzymes, mRNAs, and other biomolecules are unavoidable and appear sufficient to shift cells between transcriptional on and off states [8] . With some cells randomly active and others dormant, the computational result is a distribution of cell fates across a population. That is, the models showed that stochastic fluctuations in gene expression enable the phage to mediate between its two alternate developmental fates without sensor-actuator circuitry.
The first experimental evidence for the theory that molecular fluctuations could drive a developmental bethedging decision was found in another virus: the human immunodeficiency virus type 1 (HIV), which probabilistically chooses between active transcription and a latent state [9] . HIV has become a useful model to experimentally elucidate core principles underlying stochastic bet-hedging, and the principles discovered in HIV have been generalized to fate-selection decisions occurring in bacteria [10] , stem-cell reprogramming [11, 12] , and cancer drug tolerance [13] . Below, these core principles of fate-selection are reviewed in the context of the HIV latency decision.
HIV latency: a bet-hedging strategy to optimize viral transmission Upon infecting CD4 + T lymphocytes, HIV either actively replicates to rapidly produce progeny virions or enters a long-lived quiescent state (proviral latency), from which it subsequently reactivates [14] . Latently infected cells form a viral reservoir, enabling life-long viral persistence and necessitating lifelong antiretroviral therapy (ART) for HIV-infected individuals. The evolutionary conundrum was how latency had been maintained over the centuries of natural lentiviral infections in non-human primates before the current ART era, given the rapid evolution of the virus.
Historically, the prevailing dogma in retrovirology had been that HIV latency played no role during HIV's natural history of infection [14, 15] . In the absence of ART, latency was thought to be a deleterious phenotype, since latently infected cells produce no virus and decrease viral loads. Given latency's reduction of lentiviral replicative fitness, latency seemed to be an evolutionary accident -an 'epiphenomenon' reflecting serendipitous lentiviral infection of some CD4 + T cells precisely during their transition from an activated state to a quiescentmemory state [16] [17] [18] . Latency was therefore viewed as an infrequent bystander effect that occurs only after a virus-driven adaptive immune response begins and CD4 + T lymphocytes start to form memory subsets.
However, several findings were inconsistent with this dogma. First, in Rhesus monkeys, viral latency is rapidly established long before the adaptive immune response begins [19 ] . Second, in patient cells, reactivation of quiescent-memory cells infected with latent HIV did not necessarily reactivate the latent virus [20 ,21] . Third, latency occurs with high frequency in cell culture (50% of infected cells establish latency), despite the absence of immune responses or any cellular relaxation to memory [22 ,23] . Fourth, remarkably, HIV's Tat feedback circuit is sufficient to generate a probabilistic bet-hedging decision in the absence of cellular relaxation, and the molecular architecture of the circuit appears optimized to generate a bet-hedging decision [9, 24, 25] (described in more detail below).
If latency were a non-beneficial viral trait or an epiphenomenon, the latency phenotype should have been lost due to natural selection or genetic drift -given the rapid evolution of lentiviruses -and the viral gene-regulatory circuitry should have evolved away from being an intrinsic latency generator. The persistence of this virus-encoded latency circuit suggested an unknown selective advantage that counterbalances latency's putative fitness cost (i.e., reduced long-term viral loads).
To address this discrepancy, Rouzine et al. [26 ] examined whether latency could provide a fitness advantage during initial infection, when the virus must pass through the target-cell-poor mucosa, where >90% of HIV infections start [27] ; the evolutionary precursor to HIV in humans -SIV in non-human primates -also spreads through mucosal transmission [28] . In target-poor environments (e.g., the early mucosa) high virulence quickly depletes available targets, leaving no infectable cells at the site. Consequently, if a virus is highly virulent, the mucosal infection is extinguished before the virus can spread to the target-rich environments to generate selfsustaining systemic infection ( Figure 1 ). In fact, direct observations in macaques show that mucosal infections precipitously decay toward local extinction in the first few days after inoculation [27, 29] .
Rouzine et al. [26 ] built off patient-validated models [30] to calculate what the optimum bet-hedging frequency would be, given the inherent cost-benefit tradeoff latency generates between systemic and mucosal infection. Surprisingly, they found the optimal bet-hedging frequency was 50% latency, the same latency frequency typically found in infections of cultured T lymphocytes. Incorporating immune responses into the model enabled the authors to fit all available patient data, including a far lower latency frequency [26 ] . A recent clinical study in patients [31 ] further supports the model that latency is a bet-hedging adaptation to optimize transmission through the target-poor mucosa.
Molecular architecture of HIV's bet-hedging circuit
For many years, the absence of a viable evolutionary fitness argument bolstered the notion that HIV proviral latency was a bystander effect (i.e., epiphenomenon) ineludibly resulting from transcriptional silencing during relaxation of activated lymphocytes to a quiescent-memory state (Figure 2a ). However, despite the vast literature of associative evidence linking latent HIV integration sites to silenced chromatin and correlating latency with cellular silencing [32, 33] , there was also evidence for an alternate model where latency was controlled by viral gene-regulatory circuitry [9, 20, 34] without strict dependence on cellular state (Figure 2a) . Critically, the hypothesis that latency establishment was driven by cellular state had never been directly tested (i.e., lymphocytes had never been infected and tracked in real time as they underwent relaxation to memory).
The first direct test between these models was only recently carried out. Razooky The evolutionary role of latency; schematic of two competing HIV strains during early infection -a hypothetical latency-incapable strain (upper) and the extant latencycapable strain (lower). Infection begins with viral inoculation in the mucosa and progresses -in some cases -to systemic infection in the lymphoid tissue, where >98% of CD4 + T cells reside [48] . An HIV strain incapable of entering latency would generate increased viral loads during systemic infection, transferring more virions to new hosts. However, the latencyincapable virus would rapidly destroy the small CD4 + T cell population initially present in the mucosa of the new host -reducing the probability of systemic infection. In contrast, an HIV strain capable of probabilistically entering latency (i.e., bet hedging) would generate lower viral loads during target-rich systemic infection, transferring fewer virions to new hosts, yet, the relatively few transferred virions would not destroy all mucosal target cells. By entering long-lived latency in some mucosal cells, the latencycapable strain increases its probability of surviving initial infection to establish systemic infection. Calculations of the optimal bet-hedging frequency for latency to constitute an evolutionary stable strategy match observed frequencies of latency in cell culture [26 ] . + T cells, derived from human donors, were activated to enable HIV infection, infected with a single-round HIV (envdeleted and expressing a short-lived GFP), and cells were then allowed to relax to resting memory (by removal of activation stimuli). HIV expression and cellular activation levels were tracked for two weeks by flow cytometry. (c) Transitioning of primary T lymphocytes from activated to resting did not silence HIV expression as assayed by flow cytometry analysis of CD25/CD69 cell-activation markers and viral GFP expression. Although cells fully relax from activated to resting, viral gene expression does not silence (even despite extension of infected-cell lifetime due env deletion). Data shown from duplicate infections performed on cells from two donors (adapted from [35 ] ).
donors, activated the cells to enable HIV infection, and infected them with a single-round HIV (env-deleted) expressing a short-lived green fluorescent protein (GFP) (Figure 2b ). The activated cells were then allowed to relax to resting memory (by removing activation stimuli), and HIV expression and cellular activation levels were tracked by flow cytometry. Strikingly, transitioning of primary T lymphocytes from activated to resting did not silence HIV expression (Figure 2c ), demonstrating that HIV expression during establishment of latency was The architecture of HIV's minimal bet-hedging circuit. (a) Schematic of the HIV fate-selection circuit. The HIV LTR promoter fluctuates between a transcriptional elongation-competent (ON) state and a non-elongation-competent (OFF) state [36, 38] . In the ON state, Tat protein, can transactivate the LTR to enhance transcription (by promoting elongation of RNA polymerases stalled on the LTR) comprising a positive-feedback circuit that amplifies expression 100 fold, for review see [40] . (b) Stochastic simulations of this minimal circuit show that molecular fluctuations can generate a phenotypic bifurcation in cellular Tat levels where Tat levels will fluctuate to zero in some cells (i.e., trajectories) but not in other (genetically identical) cells [35 ] . (c) Experimental evidence (flow cytometry) that a minimal LTR-Tat-GFP feedback circuit is sufficient to generate a phenotypic bifurcation in genetically identical clones [9] . Abrogating Tat positive feedback eliminates the phenotypic bifurcation both computationally and experimentally [9, 49] . (d) A synthetic Tat feedback circuit (left) validates model predictions that the minimal Tat positivefeedback circuit is sufficient to account for the circuit turning on and off (middle) and for HIV resilience to cellular silencing (right). The FKBP proteolysis domain causes Tat to rapidly degrade (abrogating positive feedback), but the small molecule Shield-1 inhibits FKBP-mediated degradation and allows Tat to assume its native half-life and complete the positive feedback loop. Cellular relaxation experiment performed as in Figure 2b but cells were transduced with the minimal-synthetic circuit and feedback was chemically modulated using Shield-1 [35 ] .
resilient to cellular state and pointing to an intrinsic viral program controlling the establishment of latency.
To determine the mechanisms that might comprise the viral program, mathematical modeling of the HIV circuit was used to define the minimal core principles that could enable a fate-selection decision and allow the fate decision to be resilient to cellular relaxation. Previous singlecell studies had determined that HIV's long-terminal repeat (LTR) promoter, the virus's only promoter, is exceptionally noisy [36] ; the dominant noise source is large, infrequent 'bursts' of transcription [37, 38] such that the promoter can be modeled using a two-state 'random telegraph' model [38] . It was also known that LTR noise is amplified by positive feedback from HIV's Tat protein, which transactivates the LTR [39] . Thus, the viral circuit can be modeled as a two-state promoter with positive feedback (Figure 3a) . Stochastic simulations of this minimal Tat-feedback circuit recapitulated a phenotypic bifurcation between a transcriptionally active and latent state (Figure 3b) , which matched the original experimental observation [9] that a minimal Tat positive-feedback circuit is sufficient to generate a phenotypic bifurcation in genetically identical cells (Figure 3c) . Importantly, the simulations showed that the bifurcation can occur largely independent of cell state [35 ] .
To experimentally test the mathematical model that Tat circuitry by itself can establish HIV latency independent of cellular state, a synthetic biology approach was used [35 ] . A minimal synthetic Tat-feedback circuit was constructed that allowed tuning of feedback strength through chemically modulated proteolysis (Figure 3d) . Then, the primary-cell cellular-relaxation experiment was repeated to determine if the minimal Tat circuit was resilient to cellular silencing, as was the full-length virus. As predicted, when Tat feedback was abrogatedby rapid proteolysis of Tat -HIV transcription was silenced as the cells became quiescent. But, when Tat proteolysis was chemically blocked by a small molecule (Shield-1), Tat feedback alone was sufficient to overcome the cellular silencing during relaxation to quiescence in the primary T cells (Figure 3d ). The results demonstrate that Tat feedback is necessary and sufficient to establish HIV latency independent of cellular silencing.
How does HIV achieve this paradoxical functioning? Specifically, how is HIV simultaneously resistant to the global effects of cellular silencing while sensitive enough to molecular fluctuations to allow these to drive transcriptional switching?
The regulatory circuit architecture provides a mechanism. Although the LTR responds to external stimuli, the response is relatively small -strong transcriptional activators (e.g., TNF, which induces changes in NFkB) generate only 2-fold changes in LTR expression [9, 24, 40] . In contrast, Tat transactivation increases LTR expression by >50-fold. This strong positive feedback from Tat transactivation effectively insulates the circuit from the relatively weak effects of cell-state changes and other external stimuli. The only mechanisms that can significantly influence the activated circuit are those that disrupt feedback, such as the large stochastic bursts that are intrinsic to LTR expression and that are amplified by Tat feedback. The resulting Tat fluctuations can be so extreme that Tat molecules are completely depleted, which is sufficient to drive probabilistic switching to an off state [24, 40] . Essentially, during a large fluctuation the system can fluctuate into zero Tat molecules, which constitutes a 'molecular extinction', from which there is no recovery; this is analogous to a self-replicating system (e.g. bacterial division) where a fluctuation to a population size of zero results in extinction. For the HIV circuit, transcriptional elongation from the LTR promoter is so weak in many integration sites that the circuit approximates a self-replicating system: Tat can only be produced when Tat is present to transactivate the LTR. Overall, positive feedback is the core mechanism that enables the circuit to be flipped by stochastic transcriptional fluctuations even when deterministic processes are unable to flip the switch [35 ] .
Two functional aspects of the circuit are worth highlighting from an evolutionary perspective. First, comparable positive-feedback architecture had been proposed on theoretical grounds to be an unreliable environmental sensor in fluctuating environments [43] . Thus, HIV's circuit architecture is precisely the opposite of what would be expected for an environmental sensor that would respond reliably to cellular changes. Second, high-magnitude noise, as exhibited by the LTR, is generally deleterious, being selected against and filtered out of regulatory circuits [41, 42] . So, the high level of noise in HIV circuitry is extraordinary given the virus's rapid evolutionary rate, supporting the concept that expression noise is selectively beneficial for HIV's fate decision. Hence, viral evolution appears to have selected for circuitry that both maintains strong autonomy from environmental cues and simultaneously drives probabilistic on-off decisions.
Conclusion: bet-hedging circuits as targets for therapy
Stochastic noise is now considered a fundamental process driving diverse cell-fate decisions [11] [12] [13] and is recognized as a primary clinical barrier to reversing latency in patients (i.e., curing HIV) [21, 44, 45] . Decoding of the core fate-selection circuit in HIV recently led to development of several new therapeutic avenues.
On the one hand, newly designed Tat-feedback inhibitors block latent reactivation in patient samples [46 ] , demonstrating the critical role of the Tat circuit in laten- v v va a a a a a a a a a at t t to to o Controlling bet-hedging circuitry through noise modulation. (a) Conceptual basis for noise modulation. Left: chemical-reaction efficiency is enhanced not only by catalysts but also by increasing the thermal energy (i.e., kT in the Arrhenius equation). Although catalysts deterministically lower activation-energy barriers on potential-energy landscapes, amplifying thermal fluctuations (e.g., via a Bunsen burner) provides an added perturbation for crossing activation-energy barriers. Right: On a Waddington epigenetic landscape, small-molecule enhancement of stochastic gene-expression fluctuations is analogous to increasing thermal fluctuations in chemical systems. (b) Identification of small molecules that enhance noise in HIV gene expression. Left: LTR-GFP construct and schematic histograms of cells exposed to either a transcriptional activator or a noise enhancer. Right: Each point represents flow cytometry analysis of 50 000 LTR-GFP-expressing cells exposed to a compound; 85 transcriptional noise enhancers identified from among 1600 FDA-approved drugs (red) are shown as in [47 ] ; the effect of TNF or PMA (activators) is shown in blue. (c) Noise-enhancer molecules (labeled V12, V13, among others) synergize with conventional activators such as PMA (blue) and significantly modulate HIV's fate decision by enhancing (purple) reactivation of latent HIV in donor-derived human primary T cells [47 ] .
cy. On the other hand, studies of LTR noise laid the foundation for an orthogonal approach of enhancing geneexpression noise to reactivate and kill latently infected cells (Figure 4a ). This strategy [47 ] has potential to direct cellfate across a broad class of biological systems and is conceptually similar to approaches in physical and chemical systems where fluctuations are amplified to drive a system over a barrier. Indeed Dar et al. identified [47 ] a set of FDAapproved small molecules that modulate noise in LTR expression without altering the mean level of LTR expression (Figure 4b) . Strikingly, these noise-modulating compounds -which would be overlooked in conventional screens -synergized with conventional transcriptional activators and increased reactivation of latent HIV (Figure 4c ). As FDA-approved compounds, noise enhancers have potential therapeutic application to HIV and possibly other clinically relevant cell-fate decisions [11] [12] [13] .
In conclusion, noise-driven cell-fate decisions are likely a primitive biological phenomenon and it appears possible to exploit the underlying noise as a clinical tool to reverse microbial persistence and potentially reprogram cell fate in general.
